Curcumin as a putative antidepressant

Ho Jun Seo, Sheng Min Wang, Changsu Han, Soo Jung Lee, Ashwin A. Patkar, Prakash S. Masand, Chi Un Pae

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Due to inadequate efficacy of antidepressants, various new chemical entities and agents of natural origin have been tested for therapeutic efficacy both alone and to augment existing antidepressants, producing varied clinical results. This article summarizes the basic properties of curcumin and its mechanisms of action, with specific emphasis on the etiopathogenesis of depression, preclinical and current clinical evidence, and future research directions, to better understand the possible role of curcumin in treating depression. Curcumin may have antidepressant activities with diverse mechanisms of action involving primarily neurotransmitters, transcription pathways, neurogenesis, the hypothalamic-pituitary-adrenal axis and inflammatory and immune pathways, as demonstrated in various animal and human studies. Current published randomized clinical trials suggest a small, non-significant benefit of curcumin for major depression. More adequately-powered and methodologically improved studies are mandatory.

Original languageEnglish
Pages (from-to)269-280
Number of pages12
JournalExpert Review of Neurotherapeutics
Volume15
Issue number3
DOIs
Publication statusPublished - 2015 Mar 1

Fingerprint

Curcumin
Antidepressive Agents
Neurogenesis
Neurotransmitter Agents
Randomized Controlled Trials
Therapeutics

Keywords

  • antidepressant
  • curcumin
  • depression
  • mechanism of action

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Seo, H. J., Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S., & Pae, C. U. (2015). Curcumin as a putative antidepressant. Expert Review of Neurotherapeutics, 15(3), 269-280. https://doi.org/10.1586/14737175.2015.1008457

Curcumin as a putative antidepressant. / Seo, Ho Jun; Wang, Sheng Min; Han, Changsu; Lee, Soo Jung; Patkar, Ashwin A.; Masand, Prakash S.; Pae, Chi Un.

In: Expert Review of Neurotherapeutics, Vol. 15, No. 3, 01.03.2015, p. 269-280.

Research output: Contribution to journalArticle

Seo, HJ, Wang, SM, Han, C, Lee, SJ, Patkar, AA, Masand, PS & Pae, CU 2015, 'Curcumin as a putative antidepressant', Expert Review of Neurotherapeutics, vol. 15, no. 3, pp. 269-280. https://doi.org/10.1586/14737175.2015.1008457
Seo HJ, Wang SM, Han C, Lee SJ, Patkar AA, Masand PS et al. Curcumin as a putative antidepressant. Expert Review of Neurotherapeutics. 2015 Mar 1;15(3):269-280. https://doi.org/10.1586/14737175.2015.1008457
Seo, Ho Jun ; Wang, Sheng Min ; Han, Changsu ; Lee, Soo Jung ; Patkar, Ashwin A. ; Masand, Prakash S. ; Pae, Chi Un. / Curcumin as a putative antidepressant. In: Expert Review of Neurotherapeutics. 2015 ; Vol. 15, No. 3. pp. 269-280.
@article{d69ae5a8b3364d4f9e064c7453d3826b,
title = "Curcumin as a putative antidepressant",
abstract = "Due to inadequate efficacy of antidepressants, various new chemical entities and agents of natural origin have been tested for therapeutic efficacy both alone and to augment existing antidepressants, producing varied clinical results. This article summarizes the basic properties of curcumin and its mechanisms of action, with specific emphasis on the etiopathogenesis of depression, preclinical and current clinical evidence, and future research directions, to better understand the possible role of curcumin in treating depression. Curcumin may have antidepressant activities with diverse mechanisms of action involving primarily neurotransmitters, transcription pathways, neurogenesis, the hypothalamic-pituitary-adrenal axis and inflammatory and immune pathways, as demonstrated in various animal and human studies. Current published randomized clinical trials suggest a small, non-significant benefit of curcumin for major depression. More adequately-powered and methodologically improved studies are mandatory.",
keywords = "antidepressant, curcumin, depression, mechanism of action",
author = "Seo, {Ho Jun} and Wang, {Sheng Min} and Changsu Han and Lee, {Soo Jung} and Patkar, {Ashwin A.} and Masand, {Prakash S.} and Pae, {Chi Un}",
year = "2015",
month = "3",
day = "1",
doi = "10.1586/14737175.2015.1008457",
language = "English",
volume = "15",
pages = "269--280",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Curcumin as a putative antidepressant

AU - Seo, Ho Jun

AU - Wang, Sheng Min

AU - Han, Changsu

AU - Lee, Soo Jung

AU - Patkar, Ashwin A.

AU - Masand, Prakash S.

AU - Pae, Chi Un

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Due to inadequate efficacy of antidepressants, various new chemical entities and agents of natural origin have been tested for therapeutic efficacy both alone and to augment existing antidepressants, producing varied clinical results. This article summarizes the basic properties of curcumin and its mechanisms of action, with specific emphasis on the etiopathogenesis of depression, preclinical and current clinical evidence, and future research directions, to better understand the possible role of curcumin in treating depression. Curcumin may have antidepressant activities with diverse mechanisms of action involving primarily neurotransmitters, transcription pathways, neurogenesis, the hypothalamic-pituitary-adrenal axis and inflammatory and immune pathways, as demonstrated in various animal and human studies. Current published randomized clinical trials suggest a small, non-significant benefit of curcumin for major depression. More adequately-powered and methodologically improved studies are mandatory.

AB - Due to inadequate efficacy of antidepressants, various new chemical entities and agents of natural origin have been tested for therapeutic efficacy both alone and to augment existing antidepressants, producing varied clinical results. This article summarizes the basic properties of curcumin and its mechanisms of action, with specific emphasis on the etiopathogenesis of depression, preclinical and current clinical evidence, and future research directions, to better understand the possible role of curcumin in treating depression. Curcumin may have antidepressant activities with diverse mechanisms of action involving primarily neurotransmitters, transcription pathways, neurogenesis, the hypothalamic-pituitary-adrenal axis and inflammatory and immune pathways, as demonstrated in various animal and human studies. Current published randomized clinical trials suggest a small, non-significant benefit of curcumin for major depression. More adequately-powered and methodologically improved studies are mandatory.

KW - antidepressant

KW - curcumin

KW - depression

KW - mechanism of action

UR - http://www.scopus.com/inward/record.url?scp=84923328010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923328010&partnerID=8YFLogxK

U2 - 10.1586/14737175.2015.1008457

DO - 10.1586/14737175.2015.1008457

M3 - Article

C2 - 25644944

AN - SCOPUS:84923328010

VL - 15

SP - 269

EP - 280

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 3

ER -